| 1 |
34538755 | Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis. | 2021 Nov |
2 |
| 2 |
30056216 | EMPIRE-CF: A phase II randomized placebo-controlled trial of once-daily, oral acebilustat in adult patients with cystic fibrosis - Study design and patient demographics. | 2018 Sep |
1 |
| 3 |
27792868 | Phase I Studies of Acebilustat: Pharmacokinetics, Pharmacodynamics, Food Effect, and CYP3A Induction. | 2017 Jan |
1 |
| 4 |
27806191 | Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. | 2017 Jan |
1 |